ArticleJACC. Case reports2026
Unilateral Renal Denervation for Refractory Hypertension in Aortic Dissection.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- "One-Stop" Simultaneous TEVAR and Renal Denervation for Stanford Type B Aortic Dissection Complicated by Refractory Hypertension.JACC. Case reports · 2026Article
- Beyond Aortic Sealing: Integrating Anatomy and Physiology in Type B Aortic Dissection.JACC. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroudRefractory hypertension in patients with aortic dissection represents an extreme therapeutic challenge, as these patients are typically excluded from renal denervation (RDN) trials due to prohibitive procedural risks. CASE SUMMARY: A 40-year-old man with refractory hypertension complicated by a chronic DeBakey Type III (Stanford Type B) aortic dissection and abdominal aortic aneurysm presented with blood pressure of 171/98 mm Hg despite quintuple therapy. Unilateral right-sided RDN was performed using a multielectrode catheter, delivering 24 ablation lesions. Postprocedure, systolic blood pressure decreased by 30 mm Hg, enabling discontinuation of 2 antihypertensive agents. DISCUSSION: This case demonstrates that unilateral RDN is safe and effective in patients with extreme vascular lesions where bilateral RDN is not suitable. The marked blood pressure response suggests heightened sympathetic drive in this population. TAKE-HOME MESSAGE: RDN is also feasible for patients with aortic dissection, and even unilateral RDN can achieve a blood pressure-lowering effect. These findings are hypothesis-generating and require prospective validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.